Ignite Creation Date:
2024-05-06 @ 10:35 AM
Last Modification Date:
2024-10-26 @ 12:32 PM
Study NCT ID:
NCT03303339
Status:
COMPLETED
Last Update Posted:
2023-02-27
First Post:
2017-09-06
Brief Title:
Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia AML
Sponsor:
Organization:
Cardiff Oncology